Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy

    NEXT STORY
    SELLAS Life Sciences Announces Review of Strategic Alternatives
    PREV STORY
    BioSig Announces Expansion of Engineering Team
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Reviva Pharmaceuticals Holdings, Inc. Reports 2020 Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News

    Global Medical Device Connectivity Market Is Expected to Reach USD 8.76 Billion by 2027 : Fior Markets

    author_avatar
    NASDAQ Market News

    Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2018

    CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company ...

    author_avatar
    NASDAQ Market News